Lenka Šmardová

601 total citations
28 papers, 407 citations indexed

About

Lenka Šmardová is a scholar working on Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lenka Šmardová has authored 28 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lenka Šmardová's work include Lymphoma Diagnosis and Treatment (11 papers), Reproductive Biology and Fertility (8 papers) and Lung Cancer Treatments and Mutations (5 papers). Lenka Šmardová is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Reproductive Biology and Fertility (8 papers) and Lung Cancer Treatments and Mutations (5 papers). Lenka Šmardová collaborates with scholars based in Czechia, Germany and Netherlands. Lenka Šmardová's co-authors include Peter Borchmann, Andreas Engert, Volker Diehl, Zdeněk Král, Pavel Ventruba, Martin Hüser, Igor Crha, Heinz Haverkamp, Robert Hudeček and Andreas Josting and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Human Reproduction.

In The Last Decade

Lenka Šmardová

26 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lenka Šmardová Czechia 9 256 220 125 108 86 28 407
Annette Pluetschow Germany 8 262 1.0× 174 0.8× 121 1.0× 92 0.9× 113 1.3× 14 384
T. K. Saikia India 8 153 0.6× 95 0.4× 73 0.6× 80 0.7× 99 1.2× 19 334
Edita Kabíčková Czechia 11 295 1.2× 179 0.8× 150 1.2× 61 0.6× 96 1.1× 41 460
Giorgia Annechini Italy 10 147 0.6× 132 0.6× 60 0.5× 23 0.2× 66 0.8× 25 287
D E Austin United Kingdom 9 201 0.8× 109 0.5× 68 0.5× 99 0.9× 81 0.9× 12 405
Rosaria Sancetta Italy 8 317 1.2× 89 0.4× 114 0.9× 151 1.4× 57 0.7× 10 422
Christine F. Wogan United States 8 306 1.2× 173 0.8× 162 1.3× 77 0.7× 33 0.4× 18 397
Anne Kirsti Blystad Norway 10 231 0.9× 185 0.8× 51 0.4× 41 0.4× 32 0.4× 14 328
Maya Hacini France 6 285 1.1× 189 0.9× 81 0.6× 31 0.3× 35 0.4× 15 358
S. Wiedenmann Germany 8 278 1.1× 182 0.8× 94 0.8× 66 0.6× 38 0.4× 8 350

Countries citing papers authored by Lenka Šmardová

Since Specialization
Citations

This map shows the geographic impact of Lenka Šmardová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenka Šmardová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenka Šmardová more than expected).

Fields of papers citing papers by Lenka Šmardová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenka Šmardová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenka Šmardová. The network helps show where Lenka Šmardová may publish in the future.

Co-authorship network of co-authors of Lenka Šmardová

This figure shows the co-authorship network connecting the top 25 collaborators of Lenka Šmardová. A scholar is included among the top collaborators of Lenka Šmardová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenka Šmardová. Lenka Šmardová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halámková, Jana, et al.. (2021). Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients. Cancer Epidemiology. 72. 101929–101929. 3 indexed citations
2.
Vlčková, Eva, et al.. (2017). Chemotherapy-induced polyneuropathy. Neurologie pro praxi. 18(1). 25–31. 7 indexed citations
3.
Sasse, Stephanie, Horst Müller, Lenka Šmardová, et al.. (2015). Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group. Leukemia & lymphoma. 57(5). 1067–1073. 9 indexed citations
4.
Hüser, Martin, Lenka Šmardová, Petr Janků, et al.. (2015). Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues. Journal of Assisted Reproduction and Genetics. 32(8). 1187–1193. 12 indexed citations
5.
Adam, Zdeněk, Petr Szturz, Zdeněk Řehák, et al.. (2015). [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].. PubMed. 61(3). 251–9. 1 indexed citations
6.
Sasse, Stephanie, Horst Mueller, Lenka Šmardová, et al.. (2012). Prognostic Relevance of Dose-Density of DHAP-Reinduction Therapy in Relapsed HL: An Analysis of the German Hodgkin-Study Group (GHSG). Blood. 120(21). 552–552. 3 indexed citations
7.
Szturz, Petr, Mojmír Moulis, Lenka Šmardová, et al.. (2012). [Our experience in treatment of multicentric plasma-cell Castleman disease associated with vasculitis manifestations - case report and literature review].. PubMed. 58(9). 679–90. 2 indexed citations
8.
Hüser, Martin, Jana Žáková, Igor Crha, et al.. (2012). [Ovarian tissue cryopreservation in cancer patients--six years of clinical experience].. PubMed. 77(2). 118–26. 1 indexed citations
9.
Hüser, Martin, et al.. (2012). Combination of fertility preservation strategies in young women with recently diagnosed cancer.. PubMed. 33(1). 42–50. 10 indexed citations
10.
11.
Hüser, Martin, Lenka Šmardová, Pavel Ventruba, & Jean Mayer. (2010). [Impact of oncological treatment on human reproduction].. PubMed. 23(3). 165–70. 2 indexed citations
12.
Mayer, Jiřı́, Marta Krejčí, Zdeněk Pospı́šil, et al.. (2009). Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide. Experimental Hematology. 37(6). 767–773. 6 indexed citations
13.
Engert, Andreas, Hans Christian Haverkamp, Peter Borchmann, et al.. (2009). Final results of the HDR2 study – A european multicenter trial in patients with relapsed Hodgkin lymphoma.. 2 indexed citations
14.
Šmardová, Lenka, Ingrid Vášová, Milan Navrátil, et al.. (2008). Burkittův lymfom: přehled patofyziologie, diagnostiky a terapie.
15.
Hüser, Martin, Igor Crha, Pavel Ventruba, et al.. (2008). Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Human Reproduction. 23(4). 863–868. 37 indexed citations
16.
Hüser, Martin, Igor Crha, Pavel Ventruba, et al.. (2007). [Ovarian tissue cryopreservation--an opportunity to preserve fertility in women with cancer].. PubMed. 72(1). 68–73. 1 indexed citations
17.
Elbl, Lubomı́r, et al.. (2006). Evaluation of Acute and Early Cardiotoxicity in Survivors of Hodgkin's Disease Treated with ABVD or BEACOPP Regimens. Journal of Chemotherapy. 18(2). 199–208. 11 indexed citations
18.
Elbl, Lubomı́r, Ingrid Vášová, Zdeněk Král, et al.. (2006). Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults. Leukemia & lymphoma. 47(5). 843–851. 30 indexed citations
19.
Elbl, Lubomı́r, et al.. (2006). Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen.. PubMed. 53(1). 62–6. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette Pluetschow Breakdown of academic impact, for papers by T. K. Saikia Breakdown of academic impact, for papers by Edita Kabíčková Breakdown of academic impact, for papers by Giorgia Annechini Breakdown of academic impact, for papers by D E Austin Breakdown of academic impact, for papers by Rosaria Sancetta Breakdown of academic impact, for papers by Christine F. Wogan Breakdown of academic impact, for papers by Anne Kirsti Blystad Breakdown of academic impact, for papers by Maya Hacini Breakdown of academic impact, for papers by S. Wiedenmann
Rankless by CCL
2026